Vivos Therapeutics Inc
NASDAQ:VVOS
Relative Value
The Relative Value of one VVOS stock under the Base Case scenario is 17.54 USD. Compared to the current market price of 2.59 USD, Vivos Therapeutics Inc is Undervalued by 85%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
VVOS Competitors Multiples
Vivos Therapeutics Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Vivos Therapeutics Inc
NASDAQ:VVOS
|
7.7m USD | 0.6 | -0.6 | -0.4 | -0.4 | ||
US |
Cigna Corp
NYSE:CI
|
103.7B USD | 0.5 | 20.1 | 10.3 | 13.8 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
96.6B EUR | 0.5 | 20 | 10.3 | 13.7 | |
US |
CVS Health Corp
NYSE:CVS
|
86.5B USD | 0.2 | 10.4 | 8.9 | 8.9 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22B EUR | 1.1 | 44.1 | 10.3 | 24.5 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.7B USD | 1.4 | 38.6 | 11.8 | 17.7 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.5B EUR | 0.7 | -26 | 10 | 22.3 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
14.9B USD | 1.6 | 17.7 | 10.6 | 14.2 | ||
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 1 | 17.1 | 8.4 | 12.3 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.2B EUR | 0.6 | 22.4 | 6.8 | 16 | |
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |